Find policies, billing codes, payers, states, and providers
CPT 88720: Noninvasive Bilirubin Measurement, Technical Assay
CPT code 88720 represents a noninvasive laboratory test that measures bilirubin levels without skin puncture, producing a numeric result or range. This code is used for transcutaneous or other technical bilirubin assays commonly employed in neonatal screening and ambulatory bilirubin monitoring. Nationally, accurate coding for 88720 matters for clinical workflows, newborn care quality measures, and consistency in laboratory billing.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of what 88720 denotes clinically, typical sites of service where it is performed, and context relevant to laboratory service lines. The publication also addresses benchmarking and reimbursement context where available, common modifiers associated with laboratory services, and coding considerations that affect claim adjudication and reporting.
This summary equips billing managers, laboratory directors, and policy analysts with a concise reference to the clinical purpose of 88720, payer coverage scope, and the types of operational and coding topics discussed in the full publication. Data not available in the input will be noted in the relevant sections of the report.
Customize your policy alerts
Sign up for cpt 88720 policy alerts
Get alerted when payer policies referencing 88720 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 88720 describes a noninvasive bilirubin measurement in which a laboratory analyst performs the technical test to determine the amount of bilirubin without puncturing the skin. The result is reported as a numeric value or a numeric range.
Service type: Laboratory — noninvasive bilirubin measurement (transcutaneous/technical assay)
Typical site of service: Hospital outpatient department, clinic, neonatal nursery, or other ambulatory care settings where bedside or point-of-care transcutaneous bilirubin testing is performed.